Mirae Asset Mutual Fund Trims Stake in Gland Pharma to 2.95%
Gland Pharma Ltd 路 Acquisition/ Disposal of Shares 路 30 Sept 2026, 5:09 pm
Mirae Asset Mutual Fund Trims Stake in Gland Pharma to 2.95% Mirae Asset Mutual Fund reduced its holding in Gland Pharma Limited by selling 57,842 equity shares (0.04% of total voting capital) via an open market transaction on 28th Sep'26. Following the sale, the fund's equity holding decreased from 4,930,033 shares (2.99% of total voting capital and 2.96% of diluted capital) to 4,872,191 shares, representing 2.95% of total voting capital and 2.92% of total diluted share capital.
Original exchange filing (PDF)
More announcements from Gland Pharma Ltd
- Schedule of Investor Meet Intimation 路 17 Nov 2026
- Allotment of 3739 Equity Shares on exercise of ESOPs 路 16 Nov 2026
- Grant of Options to Purchase Securities 路 16 Nov 2026
- Q2FY27 Earnings Call Transcript 路 12 Nov 2026
- Gland Pharma Limited has issued Corporate Guarantee on behalf of Phixen SAS, wholly owned step down subsidiary of the Company 路 12 Nov 2026
- Appointment of Mr. Xiao Le as Chief Investment Officer at Gland Pharma International Pte. Ltd, wholly owned subsidiary of Gland Pharma Limited, effective November 09, 2026 路 09 Nov 2026
- Q2FY27 Earnings Call Recording 路 07 Nov 2026
- Q2Fy27 Investors presentation 路 06 Nov 2026
